Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia

• Monica Fung ,

  Contributed equally to this work with: Monica Fung, Sophia Koo

  * E-mail: mfung@bidmc.harvard.edu

  Affiliations Beth Israel Deaconess Medical Center, Department of Internal Medicine, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jane Kim ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Harvard T.H. Chan School of Public Health, Department of Health Policy and Management, Boston, Massachusetts, United States of America

  ⨯
• Francisco M. Marty ,

  ¶‡ These authors also contributed equally to this work.

  Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Brigham and Women’s Hospital, Division of Infectious Diseases, Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Michaël Schwarzinger ,

  ¶‡ These authors also contributed equally to this work.

  Affiliations Translational Health Economics Network, Paris, France, Decision Sciences in Infectious Disease: Prevention, Control, and Care, INSERM, IAME, Paris, France, Université Paris Diderot, IAME, Paris, France

  ⨯
• Sophia Koo

  Contributed equally to this work with: Monica Fung, Sophia Koo

  Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Brigham and Women’s Hospital, Division of Infectious Diseases, Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯